XBP1 and plasma cell myeloma: Although previous research indicated that XBP1 mRNA splicing increased in human triple-negative breast cancers (TNBCs)4, the main role of IRE1α–XBP1 signaling has been more extensively investigated in multiple myeloma because the pathway is involved in regulating mature B cell differentiation5, 6.